"The IDE Approval is beneficial in supporting our ongoing CE mark application and we remain confident of obtaining our CE Mark in the near term. Our clinical team continues to advance the engagement with leading clinicians and centres in Europe, with the aim of treating both Study subjects and commercial cases, once we achieve our CE mark."
OSL Price at posting:
14.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)